Plan of arbitrary drug price cut hits snag

Published: 2003-06-27 07:00:00

Updated: 2003-06-27 07:00:00

The pharmaceutical business sources say that under the current a new actually transacted minimum price system to have been implemented since September of last year, the government plan to make another arbitrary cutbacks of the drug prices seems unlikely possible, as four pharmaceutical firms have...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK